SEC Form 4 · accession 0001762507-26-000004
Akebia Therapeutics, Inc. · AKBA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Erik Ostrowski
Officer — SVP, CFO, CBO & Treasurer
Period of report
Jun 29, 2026
Accepted (ET)
Jul 1, 2026 · 4:34 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001517022
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 29, 2026 | S | 56,019 | $1.11 | D | 616,616 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale represents an automatic "sell to cover" transaction to cover tax withholding obligations in connection with the vesting of restricted stock units granted on June 28, 2024. The sale was effected pursuant to durable automatic sell-to-cover instructions adopted by the reporting person on September 8, 2025.